Verition Fund Management Portfolio holdings
AUM
$17.4B
1-Year Return
15.18%
This Quarter Return
+2.18%
1 Year Return
+15.18%
3 Year Return
+52.88%
5 Year Return
+61.62%
10 Year Return
+138.21%
AUM
$12.9B
AUM Growth
+$2.47B
(+24%)
Cap. Flow
+$1.2B
Cap. Flow
% of AUM
9.28%
Top 10 Holdings %
Top 10 Hldgs %
23.59%
Holding
2,708
New
547
Increased
823
Reduced
679
Closed
374
Top Buys
| 1 |
Microsoft
MSFT
|
+$956M |
| 2 |
NVIDIA
NVDA
|
+$389M |
| 3 |
Amazon
AMZN
|
+$338M |
| 4 |
Apple
AAPL
|
+$154M |
| 5 |
DTE Energy
DTE
|
+$89.5M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$587M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$62.2M |
| 3 |
Xcel Energy
XEL
|
+$62M |
| 4 |
Consolidated Edison
ED
|
+$53.7M |
| 5 |
Salesforce
CRM
|
+$48.2M |
Sector Composition
| 1 | Technology | 24.41% |
| 2 | Consumer Discretionary | 13.97% |
| 3 | Financials | 11.08% |
| 4 | Industrials | 7.81% |
| 5 | Utilities | 6.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1726
E.W. Scripps
SSP
$257M
| $245K | ﹤0.01% |
+77,956
| New | +$245K |
|
1727
Viatris
VTRS
$11.9B
| $244K | ﹤0.01% |
22,995
-17,375
| -43% | -$185K |
|
1728
Halozyme
HALO
$9.07B
| $243K | ﹤0.01% |
4,636
-1,607
| -26% | -$84.1K |
|
1729
International Bancshares
IBOC
$4.43B
| $243K | ﹤0.01% |
+4,239
| New | +$243K |
|
1730
Oric Pharmaceuticals
ORIC
$1.05B
| $242K | ﹤0.01% |
+34,228
| New | +$242K |
|
1731
iShares MSCI Philippines ETF
EPHE
$104M
| $242K | ﹤0.01% |
+10,000
| New | +$242K |
|
1732
Centrus Energy
LEU
$4.08B
| $241K | ﹤0.01% |
+5,630
| New | +$241K |
|
1733
First Foundation Inc
FFWM
$497M
| $240K | ﹤0.01% |
36,604
+5,354
| +17% | +$35.1K |
|
1734
Enbridge
ENB
$106B
| $239K | ﹤0.01% |
6,727
| – | – |
|
1735
Transcat
TRNS
$712M
| $239K | ﹤0.01% |
2,000
| – | – |
|
1736
Synaptics
SYNA
$2.76B
| $239K | ﹤0.01% |
2,705
+464
| +21% | +$40.9K |
|
1737
Greene County Bancorp
GCBC
$414M
| $239K | ﹤0.01% |
+7,077
| New | +$239K |
|
1738
Kymera Therapeutics
KYMR
$3.3B
| $237K | ﹤0.01% |
+7,956
| New | +$237K |
|
1739
TransUnion
TRU
$18.1B
| $237K | ﹤0.01% |
3,202
-799
| -20% | -$59.3K |
|
1740
Immunovant
IMVT
$2.93B
| $236K | ﹤0.01% |
8,944
-416
| -4% | -$11K |
|
1741
Ardagh Metal Packaging
AMBP
$2.14B
| $236K | ﹤0.01% |
69,400
+26,934
| +63% | +$91.6K |
|
1742
Aurora
AUR
$10.3B
| $236K | ﹤0.01% |
85,163
+74,314
| +685% | +$206K |
|
1743
Charles River Laboratories
CRL
$7.86B
| $236K | ﹤0.01% |
+1,141
| New | +$236K |
|
1744
Vaalco Energy
EGY
$417M
| $236K | ﹤0.01% |
37,586
-75,214
| -67% | -$472K |
|
1745
Quanterix
QTRX
$223M
| $235K | ﹤0.01% |
+17,761
| New | +$235K |
|
1746
JFrog
FROG
$5.82B
| $234K | ﹤0.01% |
+6,224
| New | +$234K |
|
1747
Urban Edge Properties
UE
$2.67B
| $233K | ﹤0.01% |
+12,636
| New | +$233K |
|
1748
Apogee Enterprises
APOG
$941M
| $233K | ﹤0.01% |
+3,714
| New | +$233K |
|
1749
Travere Therapeutics
TVTX
$2.23B
| $233K | ﹤0.01% |
+28,288
| New | +$233K |
|
1750
Quaker Houghton
KWR
$2.47B
| $232K | ﹤0.01% |
1,370
+196
| +17% | +$33.3K |
|